Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome development of the first disease-specific patient-reported outcome questionnaires

JAMA Dermatology

Volumn 150, Issue 2, 2014, Pages 169-176

  Mathias, Susan D ^a   Chren, Mary Margaret ^b   Colwell, Hilary H ^a   Yim, Yeun Mi ^c   Reyes, Carolina ^c   Chen, Diana M ^c   Fosko, Scott W ^d  

^a Health Outcomes Solutions   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGE; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER PATIENT; CLINICAL ARTICLE; DERMATOLOGIST; EMOTION; ETHNICITY; FEMALE; FUNCTIONAL STATUS; GENDER; HUMAN; INTERVIEW; MALE; ONCOLOGIST; OUTCOMES RESEARCH; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SCAR FORMATION; SELF REPORT; SOCIAL ASPECT; SURGEON; UNITED STATES;

ADULT; AGED; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SKIN NEOPLASMS;

EID: 84894596114     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.5870     Document Type: Article

References (14)

1. Skin Cancer Foundation. http:// www.skincancer.org/skin-cancer- information /basal-cell-carcinoma. Accessed August 28, 2012.
2. Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev. 2004;23(3-4):389-402. (Pubitemid 38881820)
3. Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg. 2005;9(1):10-15. (Pubitemid 41813569)
4. Wadhera A, FazioM, Bricca G, Stanton O. Metastatic basal cell carcinoma: a case report and literature review: how accurate is our incidence data? Dermatol Online J. 2006;12(5):7.
5. Genetics Home Reference. Gorlin syndrome. http://ghr.nlm.nih.gov/ condition/gorlin-syndrome. Accessed August 28, 2012.
6. So PL, Tang JY, Epstein EH. Novel investigational drugs for basal cell carcinoma. Expert Opin Investig Drugs. 2010;19(9):1099-1112.
7. Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007;127(6):1351-1357. (Pubitemid 46762993)
8. Ghajarzadeh M, GhiasiM, Kheirkhah S. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata. Acta Med Iran. 2012;50(7):511-515.
9. Tidman MJ. Prompt treatment of acne improves quality of life. Practitioner. 2012;256(1752):15-17.
10. Shah M, Mavers M, Bree A, Fosko S, Lents NH. Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. Int J Dermatol. 2011;50(3):268-276.
11. Burdon-Jones D, Gibbons K. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-mBCC skin cancer. J Eur Acad Dermatol Venereol. 2013;27(9):1109-1113.
12. Matthews BA, Rhee JS, NeuburgM, Burzynski ML, Nattinger AB. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg. 2006;32(7): 924-934. (Pubitemid 44034371)
13. BCCNS Life Support Network. http://www.gorlinsyndrome.org/about-bccns. aspx. Accessed August 30, 2012.
14. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105-110. (Pubitemid 32588315)